Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
  • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
  • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
  • C07H9/04—Cyclic acetals
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K39/385—Haptens or antigens, bound to carriers
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
  • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
  • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
  • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
  • A61K2039/55511—Organic adjuvants
  • A61K2039/55583—Polysaccharides
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
  • A61K2039/6031—Proteins
  • A61K2039/6062—Muramyl peptides
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
  • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
  • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
  • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Biochemistry (AREA)
• Genetics & Genomics (AREA)
• Molecular Biology (AREA)
• Biotechnology (AREA)
• Engineering & Computer Science (AREA)
• Medicinal Chemistry (AREA)
• Immunology (AREA)
• Public Health (AREA)
• Microbiology (AREA)
• Mycology (AREA)
• Pharmacology & Pharmacy (AREA)
• Epidemiology (AREA)
• Animal Behavior & Ethology (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Veterinary Medicine (AREA)
• Biophysics (AREA)
• Crystallography & Structural Chemistry (AREA)
• Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
• Peptides Or Proteins (AREA)
• Saccharide Compounds (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Applications Claiming Priority (3)

Publications (3)

Family

ID=27173419

Family Applications (2)

Family Applications After (1)

Country Status (20)

Families Citing this family (20)

Family Cites Families (5)

• 1979
  • 1979-02-21 EP EP79100513A patent/EP0003833B2/en not_active Expired - Lifetime
  • 1979-02-21 FI FI790584A patent/FI66878C/en not_active IP Right Cessation
  • 1979-02-21 CA CA000321992A patent/CA1138436A/en not_active Expired
  • 1979-02-22 IL IL7956724A patent/IL56724A/en not_active IP Right Cessation
  • 1979-02-22 ES ES477977A patent/ES477977A1/en not_active Expired
  • 1979-02-22 GR GR58433A patent/GR77615B/el unknown
  • 1979-02-23 DD DD79211204A patent/DD141616A5/en unknown
  • 1979-02-23 NO NO79790626A patent/NO151201C/en unknown
  • 1979-02-23 SU SU792739298A patent/SU1055312A3/en active
  • 1979-02-23 HU HU79CI1917A patent/HU182011B/en unknown
  • 1979-02-23 PT PT69281A patent/PT69281A/en unknown
  • 1979-02-23 AU AU44546/79A patent/AU527549B2/en not_active Expired
  • 1979-02-23 AT AT0142079A patent/AT364718B/en not_active IP Right Cessation
  • 1979-02-23 NZ NZ189756A patent/NZ189756A/en unknown
  • 1979-02-23 DK DK079779A patent/DK161026C/en not_active IP Right Cessation
  • 1979-02-23 ZA ZA79893A patent/ZA79893B/en unknown
  • 1979-02-24 PL PL1979213696A patent/PL123315B1/en unknown
  • 1979-02-24 JP JP2128179A patent/JPS54141718A/en active Granted
  • 1979-02-26 AR AR275626A patent/AR223833A1/en active
  • 1979-02-26 GB GB7906649A patent/GB2015534A/en not_active Withdrawn
  • 1979-08-22 ES ES483558A patent/ES483558A1/en not_active Expired
  • 1979-12-07 NO NO79793993A patent/NO151088C/en unknown

Also Published As

Similar Documents